GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bionet Corp (ROCO:1784) » Definitions » YoY EBITDA Growth

Bionet (ROCO:1784) YoY EBITDA Growth : -0.97% (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Bionet YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Bionet's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -0.97%.

Bionet's EBITDA per Share for the three months ended in Mar. 2024 was NT$0.92.


Bionet YoY EBITDA Growth Historical Data

The historical data trend for Bionet's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionet YoY EBITDA Growth Chart

Bionet Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.49 -34.45 79.19 42.48 29.23

Bionet Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.73 161.76 -19.07 -39.93 -0.97

Bionet YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Bionet's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(3.108-2.405)/ | 2.405 |
=29.23 %

Bionet's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(0.923-0.932)/ | 0.932 |
=-0.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bionet YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Bionet's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionet (ROCO:1784) Business Description

Traded in Other Exchanges
N/A
Address
No.28, Lane 36, Xinhu 1st Road, Neihu District, Taipei, TWN, 114065
Bionet Corp provides blood bank and stem cell services. It is a preservation center for stem cells such as Umbilical Cord Mesenchymal Stem Cells and Dental Pulp Stem Cell Stem.

Bionet (ROCO:1784) Headlines

No Headlines